| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/16/2012 | EP2451843A1 Diagnosis and treatment of autoimmune demyelinating diseases |
| 05/16/2012 | EP2451842A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 05/16/2012 | EP2451833A2 Conserved escherichia coli immunogens |
| 05/16/2012 | EP2451827A1 Chimaeric protein |
| 05/16/2012 | EP2451485A1 Lipidic compositions for induction of immune tolerance |
| 05/16/2012 | EP2451480A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 05/16/2012 | EP2451479A1 Bi-specific digoxigenin binding antibodies |
| 05/16/2012 | EP2451478A1 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/16/2012 | EP2451477A1 Plasmodium falciparum hla class i restricted t-cell epitopes |
| 05/16/2012 | EP2451475A2 Self replicating rna molecules and uses thereof |
| 05/16/2012 | EP2125009B1 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 05/16/2012 | EP1973931B1 Chicken virus vaccine and diagnostic |
| 05/16/2012 | EP1969011B1 Preparation for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 05/16/2012 | EP1861425B1 Anti-mesothelin antibodies |
| 05/16/2012 | EP1858487B1 Chemically defined stabiliser composition |
| 05/16/2012 | EP1791561B1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 05/16/2012 | CN1968712B Novel antigen-binding polypeptides and their uses |
| 05/16/2012 | CN1863556B Compositions and methods for treating coagulation related disorders |
| 05/16/2012 | CN102460163A 治疗剂和测定 Determination of the therapeutic agent and |
| 05/16/2012 | CN102459628A Anti-human cd52 immunoglobulins |
| 05/16/2012 | CN102459589A Cdc45l peptides and vaccines including the same |
| 05/16/2012 | CN102459346A Method for making heteromultimeric molecules |
| 05/16/2012 | CN102459344A Anti-axl antibody |
| 05/16/2012 | CN102459343A Anti cxcr4 antibodies for treatment of hiv |
| 05/16/2012 | CN102459342A Anti-il-3ra antibody for use in treatment of blood tumor |
| 05/16/2012 | CN102459340A 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 Granulocyte white blood cells - macrophage colony - stimulating factor (gm-csf) neutralizing antibody |
| 05/16/2012 | CN102459339A 药物制剂 Pharmaceutical preparations |
| 05/16/2012 | CN102459338A Humanized anti-egfl7 antibodies and methods using same |
| 05/16/2012 | CN102459337A Antibodies against nerve growth factor (ngf) with enhanced in vivo stability |
| 05/16/2012 | CN102459336A Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide |
| 05/16/2012 | CN102459335A 特异性结合Aβ寡聚体的抗体及其用途 Aβ oligomer-specific binding antibodies and uses thereof |
| 05/16/2012 | CN102459334A 靶定补体蛋白c3b的抗体的组合物和方法 Antibody compositions and methods of targeting of complement proteins c3b |
| 05/16/2012 | CN102459324A Casb7439构建体 Casb7439 construct |
| 05/16/2012 | CN102459323A 重组产生的过敏原 Recombinantly produced allergens |
| 05/16/2012 | CN102458478A Albumin-amyloid peptide conjugates and uses thereof |
| 05/16/2012 | CN102458471A 用于治疗或预防眼病的TNFα拮抗剂和VEGF拮抗剂的组合 TNFα antagonists and useful in the treatment or prevention of ocular VEGF antagonist combination |
| 05/16/2012 | CN102458470A Alpha thymosin peptides as vaccine enhancers |
| 05/16/2012 | CN102458469A Stable high protein concentration formulations of human anti-tnf-alpha-antibodies |
| 05/16/2012 | CN102458468A Anti-cd100 antibodies and methods for using the same |
| 05/16/2012 | CN102458467A 辅助癌症疗法 Auxiliary cancer therapy |
| 05/16/2012 | CN102458466A 使用抗-egfr剂和igf-1r特异性的抑制剂的组合治疗 Using a combination of therapeutic agents and anti--egfr igf-1r specific inhibitors |
| 05/16/2012 | CN102458465A Treatment of inflammatory diseases by inhibiting cold- inducible rna-binding protein (cirp) |
| 05/16/2012 | CN102458464A New methods for treatment of inflammatory diseases |
| 05/16/2012 | CN102458463A Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| 05/16/2012 | CN102458462A 一种温度敏感的猪肺炎支原体疫苗株及其应用 A temperature-sensitive M. hyopneumoniae vaccine strain and its Applications |
| 05/16/2012 | CN102458461A 包含减毒的牛支原体菌株的疫苗和减毒的方法 Contains attenuated Mycoplasma bovis strain attenuated vaccines and methods |
| 05/16/2012 | CN102458460A 纯化蛋白复合物的方法 Purified protein complex |
| 05/16/2012 | CN102458459A 双重可变结构域免疫球蛋白及其用途 Dual variable domain immunoglobulins and their use |
| 05/16/2012 | CN102458458A Combination immunotherapy compositions against cancer and methods |
| 05/16/2012 | CN102458457A 包含非离子等渗剂的佐剂组合物 Adjuvant composition comprising a nonionic isotonic agent |
| 05/16/2012 | CN102458456A 表达胞内多核苷酸结合蛋白的载体作为佐剂的用途 The intracellular expression of the polynucleotide binding protein vectors use as an adjuvant |
| 05/16/2012 | CN102458440A Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
| 05/16/2012 | CN102458427A Combined measles-malaria vaccine |
| 05/16/2012 | CN102458400A Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| 05/16/2012 | CN102453722A Optimization of HIV (Human Immunodeficiency Virus)-gag gene inheritance codon and preparation method and application of AIDS (Acquired Immune Deficiency Syndrome) vaccine |
| 05/16/2012 | CN102453700A Method for suspension culture of MDCK cells and for production of virus vaccines by using MDCK cells |
| 05/16/2012 | CN102453699A Method for suspension culture of sensitive cells and method for producing blue ear disease vaccine by using sensitive cells |
| 05/16/2012 | CN102453698A Method for suspension culture of subculture cells and method for producing hog cholera vaccine by using subculture cells |
| 05/16/2012 | CN102453697A Vero cell by suspension culture and method for producing viral vaccine by using Vero cell thereof |
| 05/16/2012 | CN102453096A Unlabeled tuberculosis fusion protein ESAT6-Ag85B |
| 05/16/2012 | CN102453091A Tetanus toxoid monoclonal antibody and preparation method and application thereof |
| 05/16/2012 | CN102451474A Antitumor effect, implementation method and usage of miRNA (micro-ribonucleic acid) |
| 05/16/2012 | CN102451473A MiRNA anti-tumor function, implementation method and application thereof |
| 05/16/2012 | CN101696243B Human genetic engineering antibody TRD 109 as well as preparation method and application thereof |
| 05/16/2012 | CN101595130B Compositions and methods for the diagnosis and treatment of tumor |
| 05/16/2012 | CN101541343B Use of clostridium perfringens type c bacterium for the manufacture of a vaccine |
| 05/16/2012 | CN101070536B Inducing expression of hepatitis-B virus cytomembrane small-protein and middle-protein gene in clover |
| 05/15/2012 | US8178657 Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins |
| 05/15/2012 | US8178653 Recombinant vaccines and use thereof |
| 05/15/2012 | US8178508 Methods of stimulating an immune response against prostate specific antigen |
| 05/15/2012 | US8178494 Modified human growth hormone formulations with an increased serum half-life |
| 05/15/2012 | US8178320 Artificial antibody library with super-repertory |
| 05/15/2012 | US8178308 Use of IL-27 agonists to increase interferon-gamma production |
| 05/15/2012 | US8178111 GM-negative EHV-mutants without heterologous elements |
| 05/15/2012 | US8178110 Reovirus compositions and methods of use |
| 05/15/2012 | US8178109 Compositions and methods of use for MGD-CSF in disease treatment |
| 05/15/2012 | US8178108 Methods for expression and purification of recombinant human growth hormone |
| 05/15/2012 | US8178104 Methods and compositions for targeting gC1qR/p32 |
| 05/15/2012 | US8178103 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 05/15/2012 | US8178102 Emulsified composition for dilution and cancer vaccine composition |
| 05/15/2012 | US8178101 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
| 05/15/2012 | US8178100 Antibodies to IP-10 for treating bone diseases with bone destruction |
| 05/15/2012 | US8178099 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage |
| 05/15/2012 | US8178098 Administering to the lungs of mammal an aerosolized antibody formulation comprising antibodies that selectively bind to a receptor on a T cell to reduce airway hyperresponsiveness |
| 05/15/2012 | US8178097 Methods of treatment utilizing binding proteins of the interleukin-21 receptor |
| 05/15/2012 | US8178096 Use of an anti-CD151 antibody in the treatment of cancer |
| 05/15/2012 | US8178095 Method of treating skin inflammation |
| 05/15/2012 | US8178094 Methods for inhibiting tumor growth or reducing metastatic burden in a subject by administering FDF03 antibodies |
| 05/15/2012 | US8178093 Method for treating infectious disease using monoclonal antibodies |
| 05/15/2012 | US8178092 Methods of treating psoriasis by administration of antibodies to the p40 subunit of IL-12 and/or IL-23 |
| 05/15/2012 | US8178091 Compositions and methods for the treatment of respiratory disorders |
| 05/15/2012 | US8178088 Antiprotozoal composition |
| 05/15/2012 | US8178086 Activation of HCV specific T cells |
| 05/15/2012 | US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders |
| 05/15/2012 | CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 05/15/2012 | CA2505705C Compositions and methods for the diagnosis and treatment of tumor |
| 05/15/2012 | CA2501188C Combinatorial protein library screening by periplasmic expression |
| 05/15/2012 | CA2465891C Recombinant antibodies for the detection and neutralization of anthrax toxin |
| 05/15/2012 | CA2450476C A soluble complex comprising a retroviral surface glycoprotein |
| 05/15/2012 | CA2437899C Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea |